Global burden of early pregnancy gestational diabetes mellitus (eGDM): A systematic review
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Aims Gestational diabetes mellitus (GDM) diagnosed during the first trimester of pregnancy is called ‘early pregnancy Gestational Diabetes Mellitus’ (eGDM). The burden of eGDM has only been studied sporadically. This review aims to understand the global burden of eGDM in terms of prevalence, risk factors, pregnancy outcomes, treatment and postpartum dysglycemia. Methods A review of epidemiologic studies reporting on early GDM screening as per Joanna Briggs Institute (JBI) methodology for prevalence reviews was conducted. A customized search strategy was used to search electronic databases namely, PubMed, CINAHL, EMBASE, Cochrane Library, Scopus, MEDLINE, Ovid, ScienceDirect, and Google Scholar. Three independent reviewers reviewed studies using Covidence software. Observational studies irrespective of study design and regardless of diagnostic criteria were included. Quality of evidence was appraised, and findings were synthesized. Results Of 58 included studies, 41 reported a prevalence of eGDM, ranging from 0.7 to 36.8%. Body mass index (BMI), previous history of GDM, family history of diabetes and multiparity were reported as eGDM risk factors. Adverse pregnancy outcomes associated with eGDM were macrosomia, caesarean delivery, induction of labour, hypertension, preterm delivery, and shoulder dystocia. The incidence of postpartum dysglycemia and the need for insulin was higher in women with eGDM. The risk of bias was moderate. Heterogeneity of studies is a limitation. Meta-analysis was not performed. Conclusions There is heterogeneity in the prevalence of eGDM and intrapartum and postpartum ill effects for the mother and the offspring. There is a need to develop a universal screening protocol for eGDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924 · cited 2×
“Studies that used fasting OGTT (anyone of these diagnostic criteria WHO 1999, Carpenter Coustan, JDS) have reported prevalence ranging from 1.9 to 14.2%.”
MethodInfluential2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.012 · Cited by 914
Screening criteria for high-risk gestational diabetic patients
O'Sullivan, J. B., Mahan, C. M., Charles, D., & Dandrow, R. V. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33833-9 · Cited by 478
Maternal environment and the transgenerational cycle of obesity and diabetes.
Dabelea, D., & Crume, T. (2011) · Diabetes · doi:10.2337/db11-0400 · Cited by 347
Immanuel, J., & Simmons, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0943-7 · Cited by 264 · cited 2×
“There are two other previous reviews reporting on early pregnancy screening and the outcomes of early treatment [103, 104].”
BackgroundResultSweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A. J., & Wong, J. (2016) · Diabetes Care · doi:10.2337/dc15-0433 · Cited by 263 · cited 15×
“* Viswanathan Mohan drmohans@diabetes.ind.in 1 Madras Diabetes Research Foundation - ICMR Center for Advanced Research on Diabetes and Dr. Mohan’s Diabetes Specialities Centre, No 4, Conran Smith Road, Gopalapuram, Chennai 600 086, India 2 Deakin University, Geelong, Australia 3 Women’s College Hospital, Toronto, Cana…”
BackgroundMethodResultInfluentialHughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014) · Diabetes Care · doi:10.2337/dc14-1312 · Cited by 238
Feig, D. S., Donovan, L. E., Zinman, B., Sanchez, J. J., Asztalos, E., Ryan, E. A., Fantus, I. G., Hutton, E., Armson, A. B., Lipscombe, L. L., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30310-7 · Cited by 234 · cited 1×
“According to the MiTy trial, women in the metformin group had better glycemic control, lower insulin requirements, less gestational weight gain, fewer caesarean births as compared to women in the placebo group [102].”
ResultIssues with the diagnosis and classification of hyperglycemia in early pregnancy
McIntyre, H. D., Sacks, D. A., Barbour, L. A., Feig, D. S., Catalano, P. M., Damm, P., & McElduff, A. (2016) · Diabetes Care · doi:10.2337/dc15-1887 · Cited by 181 · cited 1×
“on the grounds of insufficient evidence of benefit from earlier screening and management [14].”
BackgroundRetnakaran, R., & Shah, B. R. (2017) · Diabetes Care · doi:10.2337/dc16-1400 · Cited by 167
on behalf of the DALI Core Investigator group, Egan, A. M., Vellinga, A., Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., Adelantado, J. M., Devlieger, R., Van Assche, A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4353-9 · Cited by 152 · cited 1×
“BMI at booking for antenatal care was higher in those women with eGDM diagnosed < 12 weeks, [45] < 16 weeks [47, 52], < 20 weeks [23, 58, 67], < 24 weeks [65, 66, 79, 81, 83, 84] and at first prenatal visit [71, 73, 82].”
BackgroundCorrado, F., D’Anna, R., Cannata, M. L., Interdonato, M. L., Pintaudi, B., & Di Benedetto, A. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.03.006 · Cited by 96 · cited 9×
“Maternal age was higher by a year compared to GDM [52, 60, 66, 73, 75–79] and even up to two years in comparison with a normoglycemic group [35, 45, 52, 60, 67].”
BackgroundMethodResultInfluentialUse of hemoglobin A1c as an early predictor of gestational diabetes mellitus
Fong, A., Serra, A. E., Gabby, L., Wing, D. A., & Berkowitz, K. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.016 · Cited by 94 · cited 6×
“Maternal age was higher by a year compared to GDM [52, 60, 66, 73, 75–79] and even up to two years in comparison with a normoglycemic group [35, 45, 52, 60, 67].”
BackgroundResultInfluentialRole of first trimester HbA1c as a predictor of adverse obstetric outcomes in a multi-ethnic cohort.
Mañé, L., Flores-Le Roux, J. A., Benaiges, D., Rodríguez, M., Marcelo, I., Chillarón, J. J., Pedro-Botet, J., Llauradó, G., Gortazar, L., Carreras, R., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2581 · Cited by 91 · cited 4×
“Prepregnancy BMI was higher in those women diagnosed with GDM at < 12 weeks [35, 41, 44, 75], < 16 weeks [48], < 20 weeks [23, 56, 58, Fig.”
BackgroundResultInfluentialSesmilo, G., Prats, P., Garcia, S., Rodríguez, I., Rodríguez-Melcón, A., Berges, I., & Serra, B. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01474-8 · Cited by 60 · cited 1×
“Few other studies have shown the association between firsttrimester fasting glucose and adverse pregnancy outcomes [17, 18].”
BackgroundSweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Tan, K., Constantino, M., Harding, A. J., & Wong, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2951 · Cited by 47 · cited 8×
“On the other hand, studies that used other diagnostic criteria showed the following pregnancy outcomes higher in eGDM compared to GDM: LGA baby [66, 77, 79, 80],”
BackgroundMethodResultInfluentialBartha, J. L., Martinez-del-Fresno, P., & Comino-Delgado, R. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.112394 · Cited by 40 · cited 5×
“Maternal characteristics Maternal age was reported to be higher in eGDM women compared to those with GDM and/or normal glucose tolerance (NGT) in studies that test for GDM at < 12 weeks [35, 45, 75], < 16 weeks [52], < 20 weeks [23, 60, 67, 76], < 24 weeks [65, 66, 77–81] and during a first prenatal visit [82].”
BackgroundResultInfluentialMañé, L., Flores-Le Roux, J. A., Gómez, N., Chillarón, J. J., Llauradó, G., Gortazar, L., Payà, A., Pedro-Botet, J., & Benaiges, D. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.03.017 · Cited by 39 · cited 5×
“The adverse birth outcomes in women with eGDM reported by them were: caesarean delivery [21, 75], large for gestational age (LGA) baby [21, 45], gestational preterm delivery [45, 75], congenital anomaly [37, 45], hypertension [75], perinatal death [45], preeclampsia [45], shoulder dystocia [45], and need for induction…”
BackgroundInfluentialEarly pregnancy hemoglobin A1C and pregnancy outcomes: a population-based study
Chen, L., Pocobelli, G., Yu, O., Shortreed, S. M., Osmundson, S. S., Fuller, S., Wartko, P. D., Mcculloch, D., Warwick, S., Newton, K. M., et al. (2019) · American Journal of Perinatology · doi:10.1055/s-0038-1675619 · Cited by 36 · cited 2×
“This phenomenon of wide-ranging eGDM prevalence was also observed in other regions such as the Region of the Americas, [42, 43, 47, 65, 67, 68] Eastern Mediterranean regions, [34, 61] and African region [63].”
BackgroundHughes, R. C. E., Williman, J., & Gullam, J. E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156926 · Cited by 19
Cited by
Epidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
Self-citationPathophysiology from preconception, during pregnancy, and beyond.
Hivert, M.-F., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C. J. D., Meek, C. L., Nolan, C. J., Ram, U., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00827-4 · Cited by 186
Simmons, D., Immanuel, J., Hague, W. M., Teede, H., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M., Wong, V., Hibbert, E. J., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1667 · Cited by 36
Self-citation
Metadata
- Authors
- Hannah, W., Bhavadharini, B., Beks, H., Deepa, M., Anjana, R. M., Uma, R., Martin, E., McNamara, K., Versace, V., Saravanan, P., & Mohan, V.
- Venue
- Acta Diabetologica
- Published
- 2021-11-07
- Volume
- 59
- Issue
- 3
- Pages
- 403-427
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W3212211715
- Cited by
- 46
- References
- 26
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.